Antiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients

Graefes Arch Clin Exp Ophthalmol. 2018 Jul;256(7):1359. doi: 10.1007/s00417-018-3969-x. Epub 2018 Mar 30.

Authors

Cyril Meillon¹, Pierre Henry Gabrielle¹, Alain Bron², Catherine Creuzot-Garcher¹

Affiliations

¹ Department of Ophthalmology, University Hospital, 14 rue Paul Gaffarel, 21079, Dijon, France.
² Department of Ophthalmology, University Hospital, 14 rue Paul Gaffarel, 21079, Dijon, France. alain.bron@chu-dijon.fr.

PMID: 29602959
DOI: 10.1007/s00417-018-3969-x

No abstract available

Publication types

Letter
Comment

MeSH terms

Anticoagulants*
Aspirin
Humans
Platelet Aggregation Inhibitors
Prospective Studies
Vitreoretinal Surgery*

Substances

Anticoagulants
Platelet Aggregation Inhibitors
Aspirin